Semin Respir Crit Care Med 2017; 38(05): 677-685
DOI: 10.1055/s-0037-1606224
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Chronic Thromboembolic Pulmonary Hypertension: Advances in Therapy

Micah R. Fisher
1   Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
,
Nick H. Kim
2   Division of Pulmonary, Critical Care, and Sleep Medicine, University of California, San Diego, La Jolla, California
› Author Affiliations
Further Information

Publication History

Publication Date:
15 October 2017 (online)

Abstract

Chronic thromboembolic pulmonary hypertension is a progressive disease characterized by obstruction of the pulmonary vascular bed by insufficient resolution of thromboemboli leading to increased pulmonary vascular resistance with resultant right heart dysfunction and poor long-term survival. Estimates of cumulative incidence after an acute pulmonary embolism range from 1 to 4% within 2 years of an initial event. Current recommendations focus on screening patients being evaluated for pulmonary hypertension with ventilation/perfusion scans and then considering them for potentially curative surgery consisting of a pulmonary endarterectomy. Outcomes at high-volume surgical centers continue to improve and overall perioperative mortality is close to 2 to 4% with excellent reported long-term survival. Unfortunately, adherence with guidelines remains poor and patients with this potentially remediable disease are being missed. In addition, a significant number of patients who are diagnosed are not felt to be operative candidates based on location of disease, hemodynamics, or comorbidities. Several new advances may improve outcomes for such patients who are not operative candidates or who have persistent pulmonary hypertension after surgery, including medical therapy and balloon pulmonary angioplasty. Further studies are needed to answer questions about how best to incorporate these advances into our overall treatment algorithm.

 
  • References

  • 1 Auger WR, Fedullo PF. Chronic thromboembolic pulmonary hypertension. Semin Respir Crit Care Med 2009; 30 (04) 471-483
  • 2 Riedel M, Stanek V, Widimsky J, Prerovsky I. Long term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81 (02) 151-158
  • 3 Madani MM, Auger WR, Pretorius V. , et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012; 94 (01) 97-103 , discussion 103
  • 4 Pepke-Zaba J, Delcroix M, Lang I. , et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124 (18) 1973-1981
  • 5 Ghofrani HA, D'Armini AM, Grimminger F. , et al; CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369 (04) 319-329
  • 6 Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med 2015; 21 (05) 425-431
  • 7 Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 2010; 95 (06) 970-975
  • 8 Pengo V, Lensing AW, Prins MH. , et al; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350 (22) 2257-2264
  • 9 Guérin L, Couturaud F, Parent F. , et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost 2014; 112 (03) 598-605
  • 10 Bonderman D, Jakowitsch J, Redwan B. , et al. Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 2008; 28 (04) 678-684
  • 11 Bonderman D, Skoro-Sajer N, Jakowitsch J. , et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007; 115 (16) 2153-2158
  • 12 Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M. Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Respir J 2015; 46 (02) 431-443
  • 13 Zabini D, Heinemann A, Foris V. , et al. Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J 2014; 44 (04) 951-962
  • 14 Alias S, Redwan B, Panzenböck A. , et al. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 2014; 34 (04) 810-819
  • 15 Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103 (03) 685-692
  • 16 Dorfmüller P, Günther S, Ghigna MR. , et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J 2014; 44 (05) 1275-1288
  • 17 Forfia PR, Fisher MR, Mathai SC. , et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006; 174 (09) 1034-1041
  • 18 Pagnamenta A, Vanderpool R, Brimioulle S, Naeije R. Proximal pulmonary arterial obstruction decreases the time constant of the pulmonary circulation and increases right ventricular afterload. J Appl Physiol (1985) 2013; 114 (11) 1586-1592
  • 19 MacKenzie Ross RV, Toshner MR, Soon E, Naeije R, Pepke-Zaba J. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2013; 305 (02) H259-H264
  • 20 Giusca S, Popa E, Amzulescu MS. , et al. Is right ventricular remodeling in pulmonary hypertension dependent on etiology? An echocardiographic study. Echocardiography 2016; 33 (04) 546-554
  • 21 Kim NH, Delcroix M, Jenkins DP. , et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62 (25, Suppl): D92-D99
  • 22 McGoon M, Gutterman D, Steen V. , et al; American College of Chest Physicians. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (1, Suppl): 14S-34S
  • 23 McLaughlin VV, Langer A, Tan M. , et al; Pulmonary Arterial Hypertension-Quality Enhancement Research Initiative. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest 2013; 143 (02) 324-332
  • 24 Gall H, Preston IR, Hinzmann B. , et al. An international physician survey of chronic thromboembolic pulmonary hypertension management. Pulm Circ 2016; 6 (04) 472-482
  • 25 Stein PD, Chenevert TL, Fowler SE. , et al; PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Investigators. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010; 152 (07) 434-443 , W142-3
  • 26 Stein PD, Fowler SE, Goodman LR. , et al; PIOPED II Investigators. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354 (22) 2317-2327
  • 27 Bergin CJ, Sirlin CB, Hauschildt JP. , et al. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology 1997; 204 (03) 695-702
  • 28 Bergin CJ, Rios G, King MA, Belezzuoli E, Luna J, Auger WR. Accuracy of high-resolution CT in identifying chronic pulmonary thromboembolic disease. AJR Am J Roentgenol 1996; 166 (06) 1371-1377
  • 29 Tunariu N, Gibbs SJ, Win Z. , et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007; 48 (05) 680-684
  • 30 Freeman LM. Don't bury the V/Q scan: it's as good as multidetector CT angiograms with a lot less radiation exposure. J Nucl Med 2008; 49 (01) 5-8
  • 31 Fisher MR, Forfia PR, Chamera E. , et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179 (07) 615-621
  • 32 He J, Fang W, Lv B. , et al. Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography. Nucl Med Commun 2012; 33 (05) 459-463
  • 33 Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol 2009; 71 (01) 49-54
  • 34 Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992; 182 (02) 393-398
  • 35 Rajaram S, Swift AJ, Telfer A. , et al. 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax 2013; 68 (07) 677-678
  • 36 Ley S, Ley-Zaporozhan J, Pitton MB. , et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 2012; 22 (03) 607-616
  • 37 Auger WR, Kim NH, Trow TK. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2010; 31 (04) 741-758
  • 38 Jamieson SW, Kapelanski DP, Sakakibara N. , et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76 (05) 1457-1462 , discussion 1462–1464
  • 39 Jenkins DP, Biederman A, D'Armini AM. , et al. Operability assessment in CTEPH: Lessons from the CHEST-1 study. J Thorac Cardiovasc Surg 2016; 152 (03) 669-674.e3
  • 40 Jaïs X, D'Armini AM, Jansa P. , et al; Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008; 52 (25) 2127-2134
  • 41 Galiè N, Humbert M, Vachiery JL. , et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46 (04) 903-975
  • 42 Cannon JE, Su L, Kiely DG. , et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort. Circulation 2016; 133 (18) 1761-1771
  • 43 Simonneau G, D'Armini AM, Ghofrani HA. , et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J 2015; 45 (05) 1293-1302
  • 44 Voorburg JA, Cats VM, Buis B, Bruschke AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest 1988; 94 (06) 1249-1253
  • 45 Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001; 103 (01) 10-13
  • 46 Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart 2013; 99 (19) 1415-1420
  • 47 Fukui S, Ogo T, Morita Y. , et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 2014; 43 (05) 1394-1402
  • 48 Inami T, Kataoka M, Ando M, Fukuda K, Yoshino H, Satoh T. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One 2014; 9 (04) e94587
  • 49 Kataoka M, Inami T, Hayashida K. , et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5 (06) 756-762
  • 50 Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5 (06) 748-755
  • 51 Sugimura K, Fukumoto Y, Satoh K. , et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76 (02) 485-488
  • 52 Taniguchi Y, Miyagawa K, Nakayama K. , et al. Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention 2014; 10 (04) 518-525
  • 53 Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med 2010; 38 (4, Suppl): S495-S501
  • 54 Lankhaar JW, Westerhof N, Faes TJ. , et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006; 291 (04) H1731-H1737